Document is current
Any future updates will be listed below
-
Authors
Li, Jing
Liu, Xingzuo
Zhang, Zhiming
Wang, Hequn
Ma, Jingbo
Jiang, Yanwen
Sheng, Le
Li, Shumei
Zhang, Ji
Lin, Xinrong
Hsu, Kungchi
Tu, Yidong
Steel, Andrew
Wu, Yan
Flament, Frederic
-
Clinical Trials BETA
Clinical trials referenced in this document:
isrctn60519611 at ISRCTN.orgDocuments that mention this clinical trial
Efficacy and Tolerability of a Facial Serum Before and After Ablative Fractional Carbon Dioxide Laser: A Randomized Controlled Trial on Chinese Women
https://doi.org/10.1007/s13555-025-01531-x
-
Funding
Funding for this research was provided by:
L’Oréal Research and Innovation
- License Information
-
More Information
Article History
Received: 11 March 2025
Accepted: 26 August 2025
First Online: 26 September 2025
Declarations
:
: Jing Li, Xingzuo Liu, Zhiming Zhang, Andrew Steel, Shumei Li, Ji Zhang, Xinrong Lin, Yidong Tu, and Kungchi Hsu are full-time employees of L’Oréal Research and Innovation, Shanghai, China. Le Sheng and Hequn Wang are full-time employees of L’Oréal Research and Innovation, New Jersey, USA. Jingbo Ma is employed by the Dermatology Department, World Path Clinic International, Shanghai, China. Yanwen Jiang is employed by Shanghai China-Norm Quality Technical Service Co., Ltd. Yan Wu has received honorarium from L’Oreal as member of a dermatologist board. Frederic Flament is a full-time employee of L’Oréal Research and Innovation, Paris, France.
: This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments, with the exception that this trial was retrospectively registered under ISRCTN60519611 on ISRCTN. The study was conducted with OECD Good clinical Practices (GCP). The study was approved by the Shanghai Ethics Committee for Clinical Research (no. SECCR2021-180–01). Written informed consent to participate in the study and for the publication was provided by all patients.
